Milestone Scientific (MLSS) – Investment Analysts’ Recent Ratings Updates

Milestone Scientific (NYSE: MLSS) recently received a number of ratings updates from brokerages and research firms:

• 10/17/2024 – Milestone Scientific is now covered by analysts at StockNews.com. They set a “hold” rating on the stock.
• 10/10/2024 – Milestone Scientific is now covered by analysts at Benchmark Co.. They set a “speculative buy” rating and a $1.25 price target on the stock.
• 10/9/2024 – Milestone Scientific is now covered by analysts at StockNews.com. They set a “hold” rating on the stock.
• 10/1/2024 – Milestone Scientific is now covered by analysts at StockNews.com. They set a “hold” rating on the stock.
• 9/23/2024 – Milestone Scientific is now covered by analysts at StockNews.com. They set a “hold” rating on the stock.
• 9/15/2024 – Milestone Scientific is now covered by analysts at StockNews.com. They set a “hold” rating on the stock.
• 9/7/2024 – Milestone Scientific is now covered by analysts at StockNews.com. They set a “hold” rating on the stock.
• 8/30/2024 – Milestone Scientific is now covered by analysts at StockNews.com. They set a “hold” rating on the stock.
• 8/22/2024 – Milestone Scientific is now covered by analysts at StockNews.com. They set a “hold” rating on the stock.

Milestone Scientific Stock Performance

Shares of Milestone Scientific stock opened at $0.85 on Thursday. The stock has a 50 day moving average of $0.96 and a 200 day moving average of $0.81. The firm has a market capitalization of $65.66 million, a price-to-earnings ratio of -8.50 and a beta of 1.08. Milestone Scientific Inc. has a fifty-two week low of $0.52 and a fifty-two week high of $1.10.

Milestone Scientific (NYSE:MLSS) last announced its earnings results on Thursday, August 15th. The company reported ($0.02) earnings per share for the quarter, missing the consensus estimate of ($0.01) by ($0.01). The company had revenue of $1.85 million for the quarter. Milestone Scientific had a negative return on equity of 60.78% and a negative net margin of 54.87%.

Insider Activity at Milestone Scientific

In other Milestone Scientific news, Director Leonard Osser sold 141,913 shares of the company’s stock in a transaction on Wednesday, August 21st. The stock was sold at an average price of $0.95, for a total transaction of $134,817.35. Following the transaction, the director now directly owns 4,602,506 shares in the company, valued at $4,372,380.70. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. In the last quarter, insiders sold 143,122 shares of company stock worth $136,026. Insiders own 24.75% of the company’s stock.

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.